Gadolinium(iii) sulfate octahydrate(CAS: 13450-87-8)

Gadolinium(iii) sulfate octahydrate (CAS: 13450-87-8) is subject to regulatory guidelines under the Globally Harmonized System (GHS) for classification and labelling, including SDS and safety data management. It also falls under the European Union's REACH regulations. Additionally, FDA and EPA regulations govern its use and disposal in the United States.

Alternatives to Gadolinium(iii) sulfate octahydrate (CAS: 13450-87-8) in synthesis include other gadolinium compounds such as gadolinium chloride and gadolinium nitrate. Other rare earth compounds like lanthanum sulfate can also be used as substitutes.

The market trend for Gadolinium(iii) sulfate octahydrate (CAS: 13450-87-8) is driven by its increasing use in medical imaging due to its role in MRI contrast agents. Research is also focused on its applications in catalysis and as a precursor in the synthesis of other compounds. The demand is expected to grow with advancements in healthcare and chemical research.

Waste containing Gadolinium(iii) sulfate octahydrate (CAS: 13450-87-8) should be collected in appropriate containers, labeled clearly, and disposed of through professional waste disposal services. Proper environmental protection measures should be taken to prevent contamination. Incineration is a common disposal method, but it must be conducted in compliance with local regulations and environmental protection standards.